Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ying Yuan, Xiao-Fen Li, Jia-Qi Chen, Cai-Xia Dong, Shan-Shan Weng & Jian-Jin Huang. (2014) Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer. OncoTargets and Therapy 7, pages 841-852.
Read now
Read now
Enrico Franceschi, Marco Bartolotti, Rosalba Poggi, Monica Di Battista, Dario Palleschi & Alba A Brandes. (2014) The role of systemic and targeted therapies in brain metastases. Expert Review of Anticancer Therapy 14:1, pages 93-103.
Read now
Read now
Anna S Berghoff & Matthias Preusser. (2013) Biology in prevention and treatment of brain metastases. Expert Review of Anticancer Therapy 13:11, pages 1339-1348.
Read now
Read now
Articles from other publishers (26)
Shervin Taslimi, Karanbir Brar, Yosef Ellenbogen, Jiawen Deng, Winston Hou, Fabio Y. Moraes, Michael Glantz, Brad E. Zacharia, Aaron Tan, Manmeet S. Ahluwalia, Mustafa Khasraw, Gelareh Zadeh & Alireza Mansouri. (2021) Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Vincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, Ilaria Maggio, Lidia Gatto, Alicia Tosoni, Raffaele Lodi, Enrico Franceschi & Alba Ariela Brandes. (2021) Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases. Immunotherapy 13:5, pages 419-432.
Crossref
Crossref
Bharati Shriyan, Deepali Patil, Murari Gurjar, Manjunath Nookala, Anand Patil, Sadhana Kannan, Vijay Patil, Amit Joshi, Vanita Noronha, Kumar Prabhash & Vikram Gota. (2020) Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases. European Journal of Clinical Pharmacology 76:10, pages 1427-1436.
Crossref
Crossref
Pitchaya Wanleenuwat & Piotr Iwanowski. (2020) Metastases to the central nervous system: Molecular basis and clinical considerations. Journal of the Neurological Sciences 412, pages 116755.
Crossref
Crossref
Manmeet S. Ahluwalia, Kevin Becker & Benjamin P. Levy. (2018) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer. The Oncologist 23:10, pages 1199-1209.
Crossref
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments
33
63
.
G. Goss, C.-M. Tsai, F.A. Shepherd, M.-J. Ahn, L. Bazhenova, L. Crinò, F. de Marinis, E. Felip, A. Morabito, R. Hodge, M. Cantarini, M. Johnson, T. Mitsudomi, P.A. Jänne & J.C.-H. Yang. (2018) CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials. Annals of Oncology 29:3, pages 687-693.
Crossref
Crossref
Ya-Wen Sun, Jian Xu, Jun Zhou & Wen-Juan Liu. (2017) Targeted drugs for systemic therapy of lung cancer with brain metastases. Oncotarget 9:4, pages 5459-5472.
Crossref
Crossref
Yan Zheng, Chang Su, Liang Zhao & Yijie Shi. (2017) mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy. Journal of Nanobiotechnology 15:1.
Crossref
Crossref
Douglas Moore, Sara I Walker & Michael Levin. (2017) Cancer as a disorder of patterning information: computational and biophysical perspectives on the cancer problem. Convergent Science Physical Oncology 3:4, pages 043001.
Crossref
Crossref
Magnus Schou & Katarina Varnäs. (2017) PET microdosing of CNS drugs. Clinical and Translational Imaging 5:3, pages 291-298.
Crossref
Crossref
Timothy P. Heffron. (2016) Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. Journal of Medicinal Chemistry 59:22, pages 10030-10066.
Crossref
Crossref
Peter Ballard, James W.T. Yates, Zhenfan Yang, Dong-Wan Kim, James Chih-Hsin Yang, Mireille Cantarini, Kathryn Pickup, Angela Jordan, Mike Hickey, Matthew Grist, Matthew Box, Peter Johnström, Katarina Varnäs, Jonas Malmquist, Kenneth S. Thress, Pasi A. Jänne & Darren Cross. (2016) Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity. Clinical Cancer Research 22:20, pages 5130-5140.
Crossref
Crossref
A.L. Durham & I.M. Adcock. (2015) The relationship between COPD and lung cancer. Lung Cancer 90:2, pages 121-127.
Crossref
Crossref
K. S. Mak, J. F. Gainor, A. Niemierko, K. S. Oh, H. Willers, N. C. Choi, J. S. Loeffler, L. V. Sequist, A. T. Shaw & H. A. Shih. (2014) Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro-Oncology 17:2, pages 296-302.
Crossref
Crossref
Yu Yang Soon, Cheng Nang Leong, Wee Yao Koh & Ivan Weng Keong Tham. (2015) EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis. Radiotherapy and Oncology 114:2, pages 167-172.
Crossref
Crossref
F Bertolini, A Spallanzani, A Fontana, R Depenni & G Luppi. (2015) Brain metastases: an overview. CNS Oncology 4:1, pages 37-46.
Crossref
Crossref
Noah HongJung Nam JooSang Hoon ShinHo Shin GwakSeung Hoon LeeHeon Yoo. (2015) The Efficacy of Postoperative Chemotherapy for Patients with Metastatic Brain Tumors from Non-Small Cell Lung Cancer. Brain Tumor Research and Treatment 3:2, pages 108.
Crossref
Crossref
Takashi Kanou, Jiro Okami, Toshiteru Tokunaga, Daisuke Ishida, Hidenori Kuno & Masahiko Higashiyama. (2015) Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thoracic Cancer 6:1, pages 38-42.
Crossref
Crossref
Hyo Sup Shim, Ja Seung Koo & Se Hoon Kim. 2015. Brain Metastases from Primary Tumors. Brain Metastases from Primary Tumors
69
75
.
Fahed Zairi, Youssef Ouammou, Emilie Le Rhun, Rabih Aboukais, Serge Blond, Maximillien Vermandel, Valerie Deken, Patrick Devos & Nicolas Reyns. (2014) Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases. Clinical Neurology and Neurosurgery 125, pages 87-93.
Crossref
Crossref
Yang-Ki Minn, Da Lee, Woo Hyung, Ji Kim, Junjeong Choi, Seung-Ho Yang, Hotaek Song, Beom Lim & Se Kim. (2014) MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma. International Journal of Oncology.
Crossref
Crossref
Takashi Kanou, Jiro Okami, Toshiteru Tokunaga, Ayako Fujiwara, Daisuke Ishida, Hidenori Kuno & Masahiko Higashiyama. (2014) Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Surgery Today 44:7, pages 1321-1327.
Crossref
Crossref
Steven L. Wood, Maria Pernemalm, Philip A. Crosbie & Anthony D. Whetton. (2014) The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treatment Reviews 40:4, pages 558-566.
Crossref
Crossref
Soumit K. Basu, Scot C. Remick, Manish Monga & Laura F. Gibson. (2013) Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies. Clinical & Experimental Metastasis 31:2, pages 257-267.
Crossref
Crossref
Nina Martinez, Adrienne Boire & Lisa DeAngelis. (2013) Molecular Interactions in the Development of Brain Metastases. International Journal of Molecular Sciences 14:8, pages 17157-17167.
Crossref
Crossref